| 1 |
Wang C, Tian G, Yu X, Zhang X. Recent Advances in Functional Nanomaterials for Catalytic Generation of Nitric Oxide: A Mini Review. Small 2023;:e2207261. [PMID: 36808830 DOI: 10.1002/smll.202207261] [Reference Citation Analysis]
|
| 2 |
Mustafai A, Zubair M, Hussain A, Ullah A. Recent Progress in Proteins-Based Micelles as Drug Delivery Carriers. Polymers (Basel) 2023;15. [PMID: 36850121 DOI: 10.3390/polym15040836] [Reference Citation Analysis]
|
| 3 |
Lin PY, Chung YW, Chuang EY, Wang YC, Lai MC, Hsu YC, Lin CC, Hsiao YC. Cholesteric liquid crystal biosensor platform with image analysis for rapid detection of COVID-19. Front Bioeng Biotechnol 2023;11:1148446. [PMID: 36926691 DOI: 10.3389/fbioe.2023.1148446] [Reference Citation Analysis]
|
| 4 |
Chen FL, Shang LD, Lin YC, Chang BY, Hsiao YC. Label-Free, Portable, and Color-Indicating Cholesteric Liquid Crystal Test Kit for Acute Myocardial Infarction by Spectral Analysis and Naked-Eye Observation. Biosensors (Basel) 2022;13. [PMID: 36671895 DOI: 10.3390/bios13010060] [Reference Citation Analysis]
|
| 5 |
Li Y, Yoon B, Dey A, Nguyen VQ, Park JH. Recent progress in nitric oxide-generating nanomedicine for cancer therapy. J Control Release 2022;352:179-98. [PMID: 36228954 DOI: 10.1016/j.jconrel.2022.10.012] [Reference Citation Analysis]
|
| 6 |
Hashemi M, Ghadyani F, Hasani S, Olyaee Y, Raei B, Khodadadi M, Ziyarani MF, Basti FA, Tavakolpournegari A, Matinahmadi A, Salimimoghadam S, Aref AR, Taheriazam A, Entezari M, Ertas YN. Nanoliposomes for doxorubicin delivery: Reversing drug resistance, stimuli-responsive carriers and clinical translation. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.104112] [Reference Citation Analysis]
|
| 7 |
Nag OK, Lee K, Stewart MH, Oh E, Delehanty JB. Nanoparticle-based delivery of nitric oxide for therapeutic applications. Therapeutic Delivery 2022. [DOI: 10.4155/tde-2022-0024] [Reference Citation Analysis]
|
| 8 |
Gao D, Asghar S, Hu R, Chen S, Niu R, Liu J, Chen Z, Xiao Y. Recent advances in diverse nanosystems for nitric oxide delivery in cancer therapy. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.11.016] [Reference Citation Analysis]
|
| 9 |
Liu S, Han J, Chang Y, Wang W, Wang R, Wang Z, Li G, Zhu D, Bryce MR. AIE-active iridium(III) complex integrated with upconversion nanoparticles for NIR-irradiated photodynamic therapy. Chem Commun (Camb) 2022. [PMID: 35993197 DOI: 10.1039/d2cc03622c] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Zhao Y, Huang X, Zhang Z, Li H, Zan T, Bravo L. The Long Noncoding Transcript HNSCAT1 Activates KRT80 and Triggers Therapeutic Efficacy in Head and Neck Squamous Cell Carcinoma. Oxidative Medicine and Cellular Longevity 2022;2022:1-19. [DOI: 10.1155/2022/4156966] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Shen R, Peng L, Zhou W, Wang D, Jiang Q, Ji J, Hu F, Yuan H. Anti-angiogenic nano-delivery system promotes tumor vascular normalizing and micro-environment reprogramming in solid tumor. J Control Release 2022;349:550-64. [PMID: 35841997 DOI: 10.1016/j.jconrel.2022.07.015] [Reference Citation Analysis]
|
| 12 |
Yu KF, Lu TY, Li YE, Teng KC, Chen YC, Wei Y, Lin TE, Cheng NC, Yu J. Design and Synthesis of Stem Cell-Laden Keratin/Glycol Chitosan Methacrylate Bioinks for 3D Bioprinting. Biomacromolecules 2022. [PMID: 35438970 DOI: 10.1021/acs.biomac.2c00191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Liu M, Cao J, Tu Y, Huang C, Zhang M, Zheng J. An ultra-sensitive near-infrared fluorescent probe based on triphenylamine with high selectivity detecting the keratin. Analytical Biochemistry 2022. [DOI: 10.1016/j.ab.2022.114638] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Ion D, Niculescu AG, Păduraru DN, Andronic O, Mușat F, Grumezescu AM, Bolocan A. An Up-to-Date Review of Natural Nanoparticles for Cancer Management. Pharmaceutics 2021;14:18. [PMID: 35056915 DOI: 10.3390/pharmaceutics14010018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
